Billets de Michelle Dawson

Billet publié sur Twitter/X le 12/02/2013 23:06

Retour aux billets Billet précédent Billet suivant
Twitter/X Essai clinique clinicaltrials.gov Lien intégré au billet Termes sur l’autisme
Ouvrir le billet original

Infos sur le lien intégré au billet

Essai clinique

Holland Bloorview Kids Rehabilitation Hospital, McMaster University, Unity Health Toronto (2014). INtranasal OXyTocin for the Treatment of Autism Spectrum Disorders. ClinicalTrials.gov. Holland Bloorview Kids Rehabilitation Hospital.

Plus d’infos

Liens cités structurés

1 ressource citée

Essai clinique Récupéré Publication clinicaltrials.gov

Holland Bloorview Kids Rehabilitation Hospital, McMaster University, Unity Health Toronto (2014). INtranasal OXyTocin for the Treatment of Autism Spectrum Disorders. ClinicalTrials.gov. Holland Bloorview Kids Rehabilitation Hospital.

Date de publication
2014
Identifiant
NCT01788072
Auteurs
Holland Bloorview Kids Rehabilitation Hospital, McMaster University, Unity Health Toronto
Source
ClinicalTrials.gov
Type de référence
clinical_trial
Éditeur
Holland Bloorview Kids Rehabilitation Hospital
Source de métadonnées
clinicaltrials.gov

Résumé

There is substantial evidence from animal model and healthy control data, that oxytocin is involved in the modulation of social cognition. In addition, recent genetics and plasma level studies suggest a possible role for oxytocin in the pathophysiology of Autism Spectrum Disorders (ASD). As a large number of children with ASD are transitioning into adulthood and will likely require treatment, the lack of data to make meaningful treatment recommendations to facilitate adult living is an urgent issue. This study will examine the effect of intranasal oxytocin (IN-OXT) on social function in adults with ASD. It is hypothesized that IN-OXT will be superior to placebo in improving social function by the end of study treatment.

Ouvrir la source